Comparison of Outcomes in Patients With Acute Coronary Syndrome Presenting With Typical Versus Atypical Symptoms.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 12 2019
Historique:
received: 24 07 2019
revised: 16 09 2019
accepted: 16 09 2019
pubmed: 28 10 2019
medline: 2 4 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

Although typical chest pain is an important clinical feature required for diagnosis of acute coronary syndrome (ACS), many patients present with atypical complaints. The full extent and implication of this presentation is largely unknown. The study aim was to evaluate possible relations and temporal trends between presenting symptoms and outcomes in patients with ACS. Data was obtained from the Acute Coronary Syndrome Israeli Survey on patients presenting with typical chest pain versus atypical complaints, including dyspnea, nonspecific chest pain, palpitations or other. Temporal trends analysis examined the early (2000 to 2006) versus the late (2008 to 2016) period. During 2000 to 2016, 14,722 patients with ACS were enrolled; 11,508 (79%) presented with typical chest pain and 3,214 (21%) with atypical complaints. Patients with atypical complaints were older, majority female, and had more co-morbidities (p <0.001 for each). The 30-day major adverse cardiac events, 30-day mortality, and 1-year mortality rate were significantly higher in patients presenting with atypical complaints, (18% vs 13.5%, 7.7% vs 3.6%, and 15.6% vs 7.5%, respectively, p <0.001 for each). Although 1-year mortality decreased significantly over the years in patients with typical chest pain, there were no significant changes in patients who presented with atypical complaints. These results were consistent in STEMI and non-STE-ACS patients. In conclusion, ACS patients who present with atypical complaints have a less favorable outcome compared with patients who present with typical chest pain, and failed to show an improvement in mortality over the past 2 decades. Identification and utilization of guideline-recommended therapies in these high-risk patients may improve their future outcome.

Identifiants

pubmed: 31653357
pii: S0002-9149(19)31042-2
doi: 10.1016/j.amjcard.2019.09.007
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1851-1856

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Yoav Hammer (Y)

Cardiology Department, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Alon Eisen (A)

Cardiology Department, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

David Hasdai (D)

Cardiology Department, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ilan Goldenberg (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel; Israeli Association for Cardiovascular Trials, Sheba Medical Center, Tel Hashomer, Israel.

Nir Shlomo (N)

Israeli Association for Cardiovascular Trials, Sheba Medical Center, Tel Hashomer, Israel.

Tal Cohen (T)

Israeli Association for Cardiovascular Trials, Sheba Medical Center, Tel Hashomer, Israel.

Roy Beigel (R)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel; Israeli Association for Cardiovascular Trials, Sheba Medical Center, Tel Hashomer, Israel.

Ran Kornowski (R)

Cardiology Department, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.

Zaza Iakobishvili (Z)

Cardiology Department, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel; Department of Community Cardiology, Clalit Health Fund, Tel Aviv, Israel. Electronic address: zaza.iakobishvili@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH